Biological Evaluation Reports (BER) under the EU MDR

At MDS Finland, we provide comprehensive Biological Evaluation Reports (BER) and supporting documentation in accordance with Annex I and Annex II of the EU Medical Device Regulation (MDR) 2017/745. A well-structured BER is essential to demonstrate that your device is biologically safe and does not pose unacceptable risks when used as intended. Our biological evaluations are guided by ISO 10993 standards and are tailored to each product’s specific materials, intended use, and contact duration.

The BER is developed alongside the Biological Evaluation Plan (BEP), ensuring a clear, risk-based strategy for assessing biological safety, including when biocompatibility testing or justification by equivalence is appropriate.

Key Aspects of Our Biological Evaluation Services

Biological Evaluation Plan (BEP)

We begin with the creation of a structured BEP outlining the assessment strategy for your device. This includes identification of potential biological hazards, applicable endpoints, and selection of test methods based on ISO 10993-1 and relevant guidance documents.

Material Selection and Review

We evaluate the materials used in your device and their contact with the body. Our team assesses material selection decisions based on origin, processing, and history of safe use, minimizing the need for unnecessary testing.

Chemical Characterization

We support or coordinate chemical characterization studies (per ISO 10993-18), evaluating the leachable substances and extractables from your device. These studies are vital to understanding potential exposure and are often required prior to further toxicological evaluation.

Biocompatibility Testing

If testing is required, we plan and manage biocompatibility testing according to ISO 10993 standards. We select accredited laboratories, define test parameters, and ensure results are scientifically justified and properly documented in the BER.

Toxicological Evaluation

We perform or coordinate expert toxicological evaluations for any identified chemical substances or degradation products. Our analysis includes a thorough risk assessment based on toxicological thresholds and clinical relevance.

Equivalence Justification

Where applicable, we support biological safety justifications based on equivalence with existing, tested devices – reducing testing burden and regulatory delays.

BER Compilation and Submission

We compile a detailed, MDR-compliant Biological Evaluation Report (BER) that summarizes all relevant data and testing outcomes. The BER clearly presents the safety justification and integrates it into the overall technical documentation.

Why Choose MDS for Your Biological Evaluation?

Regulatory Accuracy and Expertise

Our experts have in-depth knowledge of biological evaluation under both ISO 10993 and EU MDR frameworks. We ensure your BER and BEP meet notified body expectations and regulatory standards

Efficient Testing Strategy

We take a risk-based approach that minimizes unnecessary material testing and avoids delays – focusing only on the evaluations needed to support a safe and compliant product.

Integrated Support

We coordinate testing, material analysis, and toxicological evaluation, ensuring that the biological assessment is seamlessly integrated into your device’s technical documentation.

Ensuring Biological Safety and Regulatory Compliance

With MDS Denmark’s expert support in biological evaluation, your device will meet the rigorous expectations of the EU MDR. From the initial BEP to the final BER, we guide you through every step—ensuring thorough documentation of material selection, chemical characterization, biocompatibility testing, and toxicological evaluation. Our process ensures safety, reduces risks, and supports successful market approval.